Stock A288330 BRIDGE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bridge Biotherapeutics, Inc.

Equities

A288330

KR7288330004

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
2,220 KRW +1.60% Intraday chart for Bridge Biotherapeutics, Inc. -3.48% -32.42%
03-28 Bridge Biotherapeutics Launches Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade CI
03-26 Bridge Biotherapeutics Announces Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology CI

Chart calendar Bridge Biotherapeutics, Inc.

e31917e9f46d33abff5b.00HNdsb1wphmQquywnFg6bp2uF4eva52Jp555v2iZw8.4DuXHbDN96gvMdjrgVwGg8sfjwd398cOc9gRnqmQX3ayFbQ1nIyA-TcB3A~700021c647b6032f2f5df61735722efe

Upcoming events on Bridge Biotherapeutics, Inc.

08/08/2024 Q2 2024 Earnings Release (Projected)
23/03/2025 Q4 2024 Earnings Release (Projected)
07/08/2025 Q2 2025 Earnings Release (Projected)

Past events on Bridge Biotherapeutics, Inc.

09/05/2024 Q1 2024 Earnings Release (Projected)
26/04/2024 01:30 Investor Meeting
17/03/2024 Q4 2023 Earnings Release
21/02/2024 07:30 Investor Meeting
10/11/2023 01:00 Goldman Sachs APAC Healthcare Corporate Day
04/10/2023 02:00 Investor Meeting
14/08/2023 07:00 Investor Meeting
11/08/2023 02:00 Investor Meeting
10/08/2023 Q2 2023 Earnings Release
20/07/2023 02:00 Investor Meeting
06/06/2023 20:15 BIO International Convention
10/05/2023 08:00 Investor Meeting
18/04/2023 14:00 American Association for Cancer Research Meeting - Abstract Number: 4018
14/03/2023 Q4 2022 Earnings Release
10/01/2023 22:00 Biotech Showcase
07/12/2022 05:00 Analyst Meeting - DB Financial Investment Co. Ltd.
09/11/2022 Q3 2022 Earnings Release
11/08/2022 Interim 2022 Earnings Release
08/08/2022 11:52 International Association for the Study of Lung Cancer World Conference
16/06/2022 19:45 BIO International Convention

Annual results

Fiscal PeriodDecember 2019 2023
Net sales
Billions KRW		Released
Forecast
Spread 		58,3
55,7
4.68%		0,00


EBITDA
Billions KRW		Released
Forecast
Spread 		1,07
-1,70
162.86%		0,00


EBIT
Billions KRW		Released
Forecast
Spread 		0,62
-0,98
163.04%		0,00


Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		7,23
-9,60
175.27%		0,00


Net income
Billions KRW		Released
Forecast
Spread 		1,32
-11,1
111.97%		-42,3


EPS
KRW		Released
Forecast
Spread 		137
-1 038
113.2%		-2 059


Announcement Date03/02/2018/03/24

Upcoming sector events for Bridge Biotherapeutics, Inc.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Bridge Biotherapeutics, Inc.

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 21:01 CELCUITY INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A288330 Stock
  4. Calendar Bridge Biotherapeutics, Inc.